TSTD2: A Potential Drug Target and Biomarker for Rhodanese Domain-Containing Proteins

Target Name: TSTD2

NCBI ID: G158427

TSTD2

TSTD2: A Potential Drug Target and Biomarker for Rhodanese Domain-Containing Proteins

Rhodanese domain-containing proteins (RDCP) are a family of proteins that play a crucial role in various cellular processes. These proteins are involved in a wide range of cellular functions, including cell signaling, cell division, and cytoskeletal organization. TSTD2, a member of the RDCP family, has been identified as a potential drug target and biomarker for various diseases.

History of TSTD2

TSTD2 was first identified in the 1990s as a protein that was expressed in various tissues, including brain, heart, and muscle. The protein was found to have a unique structure that was similar to that of other RDCP proteins. TSTD2 was named based on its unique T-loop and D-loop regions, which are present in all RDCP proteins.

Function of TSTD2

TSTD2 is involved in various cellular processes that are crucial for normal cellular function. One of the key functions of TSTD2 is its role in cell signaling. TSTD2 has been shown to play a role in the regulation of cell signaling pathways, including the insulin/IGF-1 signaling pathway.

TSTD2 has also been shown to be involved in the regulation of cell division. TSTD2 has been shown to play a role in the regulation of cell division in various tissues, including muscle and liver.

TSTD2 has also been shown to be involved in the regulation of cytoskeletal organization. TSTD2 has been shown to play a role in the regulation of actin dynamics and cytoskeletal organization in various tissues.

Potential Drug Target

TSTD2 has been identified as a potential drug target for various diseases. One of the key reasons for its potential as a drug target is its involvement in various cellular processes that are crucial for normal cellular function.

In addition, TSTD2 has a unique structure that makes it an attractive target for drugs. The TSTD2 protein has a unique T-loop and D-loop region that is present in all RDCP proteins. This structure makes it difficult for drugs to interact with the protein and inhibits its function.

Another potential drug target for TSTD2 is its role in the regulation of cell signaling pathways. TSTD2 has been shown to play a role in the regulation of cell signaling pathways, including the insulin/IGF-1 signaling pathway. This makes it an attractive target for drugs that are designed to inhibit or activate these pathways.

Biomarker

TSTD2 has also been identified as a potential biomarker for various diseases. One of the key reasons for its potential as a biomarker is its involvement in various cellular processes that are crucial for normal cellular function.

In addition, TSTD2 has a unique structure that makes it an attractive target for biomarkers. The TSTD2 protein has a unique T-loop and D-loop region that is present in all RDCP proteins. This structure makes it difficult for biomarkers to interact with the protein and can be used to detect changes in the protein's expression levels.

Conclusion

TSTD2 is a member of the RDCP family and has been shown to play a role in various cellular processes that are crucial for normal cellular function. As a result, TSTD2 has been identified as a potential drug target and biomarker for various diseases. Further research is needed to understand the full function of TSTD2 and its potential as a drug.

Protein Name: Thiosulfate Sulfurtransferase Like Domain Containing 2

The "TSTD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSTD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets